Kato K - Search Results

1

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.

Xu G, Nagano M, Kanezaki R, Toki T, Hayashi Y, Taketani T, Taki T, Mitui T, Koike K, Kato K, Imaizumi M, Sekine I, Ikeda Y, Hanada R, Sako M, Kudo K, Kojima S, Ohneda O, Yamamoto M, Ito E. Xu G, et al. Among authors: kato k. Blood. 2003 Oct 15;102(8):2960-8. doi: 10.1182/blood-2003-02-0390. Epub 2003 Jun 19. Blood. 2003. PMID: 12816863 Free article.

2

Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.

Xu G, Kato K, Toki T, Takahashi Y, Terui K, Ito E. Xu G, et al. Among authors: kato k. J Pediatr Hematol Oncol. 2006 Oct;28(10):696-8. doi: 10.1097/01.mph.0000212997.02554.f6. J Pediatr Hematol Oncol. 2006. PMID: 17023834

3

The landscape of somatic mutations in Down syndrome-related myeloid disorders.

Yoshida K, Toki T, Okuno Y, Kanezaki R, Shiraishi Y, Sato-Otsubo A, Sanada M, Park MJ, Terui K, Suzuki H, Kon A, Nagata Y, Sato Y, Wang R, Shiba N, Chiba K, Tanaka H, Hama A, Muramatsu H, Hasegawa D, Nakamura K, Kanegane H, Tsukamoto K, Adachi S, Kawakami K, Kato K, Nishimura R, Izraeli S, Hayashi Y, Miyano S, Kojima S, Ito E, Ogawa S. Yoshida K, et al. Among authors: kato k. Nat Genet. 2013 Nov;45(11):1293-9. doi: 10.1038/ng.2759. Epub 2013 Sep 22. Nat Genet. 2013. PMID: 24056718

4

Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.

Hama A, Yagasaki H, Takahashi Y, Nishio N, Muramatsu H, Yoshida N, Tanaka M, Hidaka H, Watanabe N, Yoshimi A, Matsumoto K, Kudo K, Kato K, Horibe K, Kojima S. Hama A, et al. Among authors: kato k. Br J Haematol. 2008 Mar;140(5):552-61. doi: 10.1111/j.1365-2141.2007.06971.x. Br J Haematol. 2008. PMID: 18275433 Free article.

5

An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.

Kojima S, Sako M, Kato K, Hosoi G, Sato T, Ohara A, Koike K, Okimoto Y, Nishimura S, Akiyama Y, Yoshikawa T, Ishii E, Okamura J, Yazaki M, Hayashi Y, Eguchi M, Tsukimoto I, Ueda K. Kojima S, et al. Among authors: kato k. Leukemia. 2000 May;14(5):786-91. doi: 10.1038/sj.leu.2401754. Leukemia. 2000. PMID: 10803507 Clinical Trial.

6

Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia.

Kondo M, Kudo K, Kimura H, Inaba J, Kato K, Kojima S, Matsuyama T, Horibe K. Kondo M, et al. Among authors: kato k. Leuk Res. 2000 Nov;24(11):951-6. doi: 10.1016/s0145-2126(00)00071-0. Leuk Res. 2000. PMID: 11086178

7

Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome.

Muramatsu H, Sakaguchi H, Taga T, Tabuchi K, Adachi S, Inoue M, Kitoh T, Suminoe A, Yabe H, Azuma E, Shioda Y, Ogawa A, Kinoshita A, Kigasawa H, Osugi Y, Koike K, Kawa K, Kato K, Atsuta Y, Kudo K. Muramatsu H, et al. Among authors: kato k. Pediatr Blood Cancer. 2014 May;61(5):925-7. doi: 10.1002/pbc.24883. Epub 2013 Dec 2. Pediatr Blood Cancer. 2014. PMID: 24302531

8

Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia.

Yagasaki H, Kojima S, Yabe H, Kato K, Kigasawa H, Sakamaki H, Tsuchida M, Kato S, Kawase T, Morishima Y, Kodera Y; Japan Marrow Donor Program. Yagasaki H, et al. Among authors: kato s, kato k. Blood. 2011 Sep 15;118(11):3186-90. doi: 10.1182/blood-2011-04-349316. Epub 2011 Jul 14. Blood. 2011. PMID: 21757619 Free article.

9

Salvage allogeneic stem cell transplantation in patients with pediatric myelodysplastic syndrome and myeloproliferative neoplasms.

Kato M, Yoshida N, Inagaki J, Maeba H, Kudo K, Cho Y, Kurosawa H, Okimoto Y, Tauchi H, Yabe H, Sawada A, Kato K, Atsuta Y, Watanabe K. Kato M, et al. Among authors: kato k. Pediatr Blood Cancer. 2014 Oct;61(10):1860-6. doi: 10.1002/pbc.25121. Epub 2014 Jun 29. Pediatr Blood Cancer. 2014. PMID: 24976435

10

Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemia.

Yoshida N, Yagasaki H, Xu Y, Matsuda K, Yoshimi A, Takahashi Y, Hama A, Nishio N, Muramatsu H, Watanabe N, Matsumoto K, Kato K, Ueyama J, Inada H, Goto H, Yabe M, Kudo K, Mimaya J, Kikuchi A, Manabe A, Koike K, Kojima S. Yoshida N, et al. Among authors: kato k. Pediatr Res. 2009 Mar;65(3):334-40. doi: 10.1203/PDR.0b013e3181961d2a. Pediatr Res. 2009. PMID: 19047918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,956 results

Search Page

Filters